Wellington Management Group LLP Avrobio, Inc. Transaction History

Wellington Management Group LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.84 - $12.6 $1.41 Million - $2.27 Million	-179,900 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $6.26 Million - $11.5 Million	-593,588 Reduced 76.74%	179,900 $2.28 Million
Q4 2020 Feb 12, 2021	SELL	$12.79 - $17.1 $1.14 Million - $1.52 Million	-89,125 Reduced 10.33%	773,488 $10.8 Million
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $715,151 - $1.07 Million	-55,054 Reduced 6.0%	862,613 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $375,403 - $707,076	30,796 Added 3.47%	917,667 $16 Million
Q1 2020 May 14, 2020	BUY	$10.08 - $27.21 $7.2 Million - $19.4 Million	714,680 Added 415.05%	886,871 $13.8 Million
Q4 2019 Feb 11, 2020	BUY	$13.05 - $21.88 $2.25 Million - $3.77 Million	172,191 New	172,191 $3.47 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.